← All candidates
Two insider buys in the last year — $368.0K in all.
2 filings on record.
PLYXPolaryx Therapeutics, Inc.
NasdaqCM · Healthcare · $113.62M
$2.40
-0.98% · Sep 16
Two insider buys in the last year — $368.0K in all.
Nothing in the last fortnight.
Price · 1Y · daily● 2 buys◆ 1 8-K
▸ hover a marker for the filing · drag to zoom · daily bars sharpen to 30-min on close ranges · 4 moves explained
AI brief · from the filings on this pagePro
The filings, the score and the setup on this page, read for you in about ten seconds — what the insiders did, and what stands against it.
Market cap
$113.62M
Float
4.3M
9% public
Short % float
Pro
The buyers
▸ each insider's past open-market buys, measured ~6 months (120 trading days) later, against the S&P over the same spans · split-adjusted · pre-scheduled 10b5-1 plan trades excluded · past outcomes, not predictions
Chief Executive Officer
Yang Alex Keun Mo
Bought $360.0K on May 27 — 88,453 sh @ $4.07, held indirect, 0.4% of their stake.
First Form 4 on file
Chief Financial Officer
Landis G. Michael
Bought $8.0K on Feb 18 — 2,867 sh @ $2.79, held direct, 1.3% of their stake.
0 of 1 position beat the S&P
The record
newest first
DateTypeInsiderOf stakeShares @ priceValue
Context
Wall St
$10.00 avg target
+316.7% vs today · 1 analyst
▸ relayed analyst opinion, which tends to run optimistic — not our forecast or advice
Earnings · EPS vs forecast
0 of 2 quarters beat
Q1 '26−$0.05 act−$0.03
Q4 '25−$0.16 act−$0.14
The file stays open
2 filings on record.
The next one will be too.
▸ SEC EDGAR · FINRA · Nasdaq — public sources only · research, not advice